Literature DB >> 12407686

Comparing proportional hazards and accelerated failure time models for survival analysis.

Jesus Orbe1, Eva Ferreira, Vicente Núñez-Antón.   

Abstract

This paper describes a method proposed for a censored linear regression model that can be used in the context of survival analysis. The method has the important characteristic of allowing estimation and inference without knowing the distribution of the duration variable. Moreover, it does not need the assumption of proportional hazards. Therefore, it can be an interesting alternative to the Cox proportional hazards models when this assumption does not hold. In addition, implementation and interpretation of the results is simple. In order to analyse the performance of this methodology, we apply it to two real examples and we carry out a simulation study. We present its results together with those obtained with the traditional Cox model and AFT parametric models. The new proposal seems to lead to more precise results. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407686     DOI: 10.1002/sim.1251

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  23 in total

1.  Trends and racial differences in the use of androgen deprivation therapy for metastatic prostate cancer.

Authors:  April P Carson; Daniel L Howard; William R Carpenter; Yhenneko J Taylor; Sharon Peacock; Anna P Schenck; Paul A Godley
Journal:  J Pain Symptom Manage       Date:  2010-05       Impact factor: 3.612

2.  Associations of Hearing Loss and Menopausal Hormone Therapy With Change in Global Cognition and Incident Cognitive Impairment Among Postmenopausal Women.

Authors:  Nicole M Armstrong; Mark A Espeland; Jiu-Chiuan Chen; Kamal Masaki; Jean Wactawski-Wende; Wenjun Li; Margery L S Gass; Marcia L Stefanick; JoAnn E Manson; Jennifer A Deal; Stephen R Rapp; Frank R Lin; Susan M Resnick
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-02-14       Impact factor: 6.053

3.  A comparison of multiple imputation and fully augmented weighted estimators for Cox regression with missing covariates.

Authors:  Lihong Qi; Ying-Fang Wang; Yulei He
Journal:  Stat Med       Date:  2010-11-10       Impact factor: 2.373

4.  Personality facets and all-cause mortality among Medicare patients aged 66 to 102 years: a follow-on study of Weiss and Costa (2005).

Authors:  Paul T Costa; Alexander Weiss; Paul R Duberstein; Bruce Friedman; Ilene C Siegler
Journal:  Psychosom Med       Date:  2014-06       Impact factor: 4.312

5.  Assessment of spatial variation in breast cancer-specific mortality using Louisiana SEER data.

Authors:  Rachel Carroll; Andrew B Lawson; Chandra L Jackson; Shanshan Zhao
Journal:  Soc Sci Med       Date:  2017-09-28       Impact factor: 4.634

6.  Temporally dependent accelerated failure time model for capturing the impact of events that alter survival in disease mapping.

Authors:  Rachel Carroll; Andrew B Lawson; Shanshan Zhao
Journal:  Biostatistics       Date:  2019-10-01       Impact factor: 5.899

7.  Accelerated failure time models provide a useful statistical framework for aging research.

Authors:  William R Swindell
Journal:  Exp Gerontol       Date:  2008-10-25       Impact factor: 4.032

8.  Prognostic factors for the survival of patients with esophageal cancer in Northern Iran.

Authors:  Mahmood Reza Ghadimi; Mahboobeh Rasouli; Mahmood Mahmoodi; Kazem Mohammad
Journal:  J Res Med Sci       Date:  2011-10       Impact factor: 1.852

9.  Family history of the cancer on the survival of the patients with gastrointestinal cancer in northern Iran, using frailty models.

Authors:  Mahmoodreza Ghadimi; Mahmood Mahmoodi; Kazem Mohammad; Hojjat Zeraati; Mahboobeh Rasouli; Mahmood Sheikhfathollahi
Journal:  BMC Gastroenterol       Date:  2011-10-01       Impact factor: 3.067

10.  Prognostic factors of survival time after hematopoietic stem cell transplant in acute lymphoblastic leukemia patients: Cox proportional hazard versus accelerated failure time models.

Authors:  Kourosh Sayehmiri; Mohammad R Eshraghian; Kazem Mohammad; Kamran Alimoghaddam; Abbas Rahimi Foroushani; Hojjat Zeraati; Banafsheh Golestan; Ardeshir Ghavamzadeh
Journal:  J Exp Clin Cancer Res       Date:  2008-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.